UNIVERSITY CURRICULUM VITAE FORMAT - …



CURRICULUM VITAE

DATE: August 14, 2018

NAME: Michael E. Shapiro, M.D.

PRESENT TITLE: Surgical Residency Assistant Program Director

Surgical Clerkship Associate Director

Rutgers-New Jersey Medical School

Attending Surgeon

Department of Surgery

University Hospital, Newark

Hackensack University Medical Center

Associate Professor Department of Surgery

Rutgers University New Jersey Medical School

HOME ADDRESS:

OFFICE ADDRESS: 185 South Orange Avenue

MSB G-526

Newark, NJ 07103

TELEPHONE NUMBER/E-MAIL ADDRESS:

Home:

Work: (973) 972-1258, michael.shapiro@rutgers.edu

CITIZENSHIP: United States

EDUCATION:

A. Undergraduate

Williams College

Williamstown, MA

B.A 9/69-6/73

B. Graduate and Professional

University of Rochester, School of Medicine and Dentistry

Rochester, NY

M.D. 9/73-5/77

POSTGRADUATE TRAINING:

A. Internship and Residencies

7/77-6/78 Intern in Surgery, Beth Israel Hospital, Boston, Massachusetts

7/78-6/80 Junior Assistant Resident, Surgery, Beth Israel Hospital, Boston, MA

7/82-6/83 Senior Assistant Resident, Surgery, Beth Israel Hospital, Boston, MA

6/83-12/83 Chief Resident in Surgery, Beth Israel Hospital, Boston, MA

B. Research Fellowships

7/80-6/82 Fellow

Department of Pathology (Immunology)

Harvard Medical School, Boston, MA

and

Department of Surgery

Beth Israel Hospital, Boston, MA

Under: Dr. Baruj Benacerraf.

C. Postdoctoral Appointments

None

MILITARY:

None

ACADEMIC APPOINTMENTS:

1983. Department of Surgery, Harvard Medical School, Clinical Fellow

1987. Department of Surgery, Harvard Medical School, Instructor in Surgery

1999. Department of Surgery, Harvard Medical School, Assistant Professor of Surgery

2001- 2013 Department of Surgery, New Jersey Medical School/UMDNJ, Associate Professor of Surgery, coterminous

2011- present Department of Surgery, St. George’s University School of Medicine, Professor of Surgery

2013-present Department of Surgery, Rutgers – New Jersey Medical School. Associate Professor of Surgery, non-tenure

HOSPITAL APPOINTMENTS:

1985. Department of Surgery, Beth Israel Hospital, Boston, Assistant in Surgery

1987. Department of Surgery, Beth Israel Hospital, Boston, Associate in Surgery

1996. Department of Surgery, Beth Israel Hospital, Boston, Associate Surgeon

1999. Department of Surgery, Beth Israel Deaconess Medical Center, Boston, Associate Surgeon

1999. Department of Surgery, Hackensack University Medical Center, Attending Surgeon

2012. Department of Surgery, Hackensack University Medical Center Section Chief, Organ Transplantation

2010. Department of Surgery, Hackensack University Medical Center, Interim Vice Chairman

2010. Department of Surgery, Hackensack University Medical Center, Interim Chairman

2012. Department of Surgery, Hackensack University Medical Center, Vice Chairman

2012- 2013 Department of Surgery, Hackensack University Medical Center, Director, Surgical Education

2013- Department of Surgery, University Hospital, Chief, Division of General Surgery

OTHER EMPLOYMENT OR MAJOR VISITING APPOINTMENTS:

2002. Scientist, David and Alice Jurist Institute for Research

2002. Senior Scientist, Jurist Institute for Research

2005-2013 Vice Medical Director, New Jersey Organ and Tissue Sharing Network

PRIVATE PRACTICE:

Beth Israel Hospital

Transplantation: Active clinical kidney transplant surgeon since 1984. Tripled number of kidney transplant annually over 1984-1996. Developed pancreas transplantation at Beth Israel Hospital with 100% patient and graft survival over the past 7 years. Sole kidney and pancreas transplant surgeon at Beth Israel Hospital until merger to form Beth Israel Deaconess Medical Center, with continued active practice in kidney and pancreas transplantation as well as 200-300 dialysis access procedures annually.

Hackensack University Medical Center

Transplantation: Started new renal transplant program in 1999, with pediatric renal transplantation and pancreas transplantation begun in 2002. Active practice of clinical transplantation, vascular access surgery, and general surgery of renal failure.

LICENSURE:

New Jersey Medical License – 25MA06880600

Massachusetts License Registration – #45631

DRUG LICENSURE:

CDS: NJ CDS – DO75712, Expiration: 10/30/19

DEA: NJ DEA – AS9236464, Expiration: 2/29/21

CERTIFICATION:

Surgery:

9/30/85 - #30724

Re-certified – 1995

Re-certified – 2005

Re-certified - 2016

MEMBERSHIPS, OFFICES AND COMMITTEE ASSIGNMENTS IN PROFESSIONAL SOCIETIES:

1986- American Society of Transplant Surgeons

1991-1994 Ethics Committee

2000-2003 Scientific Studies Committee

2018-2021 Ethics Committee

1986- Surgical Infection Society

1987- Transplantation Society

Ethics Committee, 2008-2014

1987- Fellow, American College of Surgeons

1998. Boston Surgical Society

2000- New York Surgical Society

2006- Society of Surgeons of New Jersey

HONORS AND AWARDS:

1973. Phi Beta Kappa

1973 Leverett Mears Prize in Chemistry, Williams College

1973. Associate, Sigma XI

1980. Member, Sigma XI

1983. Schering Scholar, American College of Surgeons

1985. American Surgical Association Foundation Fellow

2004 New Jersey Transplant Association, Medical Professional Award

2007 Kidney & Urology Foundation of America, National Medical Award

2017 Alpha Omega Alpha

BOARDS OF DIRECTORS/TRUSTEES POSITIONS:

New England Organ Bank

1999. Board of Directors

1996. Executive Committee

New Jersey Organ and Tissue Sharing Network

2000- Present Board of Trustees

2008. Executive Committee

2005. Board Secretary

2005-2007 Board Vice Chairman

2007-2008 Board Chairman

2009-13 Advisory Board Chairman

Organ Procurement and Transplantation Network/United Network for Organ Sharing

2013-2015 Board of Directors

SERVICE ON NATIONAL GRANT REVIEW PANELS, STUDY SECTIONS, COMMITTEES:

None

SERVICE ON MAJOR COMMITTEES:

A. International

2008-2014 The Transplantation Society Ethics Committee

B. National

2002. OPTN/United Network for Organ Sharing

1999. Hospital Representative, Region I

2012. Hospital Representative, Region 2

2011-2013 Region 2, Associate Counselor

2013-2015 Region 2 Counselor and Member of Board

Ethics Committee

1992-1994 Region I representative

1997-1999 Region I representative

2001-2004 Region II representative

2006-2008 Vice Chair

2011. Chair

2011 -2014 At-large representative

Kidney Committee

2005-2007 Region 2 representative

2007-2008 At-large member

Membership and Professional Standards Committee

1. Region 2 representative

2002- National Organ Donation Breakthrough Collaborative

2005- National Organ Transplantation Breakthrough Collaborative

2007- National Transplant Growth and Management Collaborative

1991. Associate Examiner, American Board of Surgery, Boston, MA

Regional:

1988-1997 New England Organ Bank

1988-1992 Board of Directors

1990-1996 Executive Committee

1989-1999 End Stage Renal Disease Network of New England

1989-1993 Medical Review Board

1996. Board of Directors

1997 Board of Directors

2010- present National Kidney Foundation of Greater NY/NJ

Medical Advisory Board

C. Medical School/University

1986-1988 Harvard Medical School, Boston, MA

New Pathway Surgical Clerkship Committee

2008-2009 Touro University College of Medicine

Faculty Appointments and Promotions Committee

2013-2017 Rutgers-New Jersey Medical School

Graduate Medical Education Committee

2014- Committee on Curriculum, Academic Programs and Policies

2015-2017 Rutgers University Senate

2015-2017 Senate Instruction, Curricula and Advising Committee

D. Department

2013– Residency Clinical Competency Committee

2013-2017 – Division Chiefs Committee

2017 – Grand Rounds Committee

2018 – Surgery Clerkship Committee

E. Editorial Boards

None

F. AdHoc Reviewer

New England Journal of Medicine

American Journal of Transplantation

Bioethique Online

Liver Transplantation

Journal of Bioethical Inquiry

Journal of Medical Ethics

SERVICE ON GRADUATE SCHOOL COMMITTEES:

None

SERVICE ON HOSPITAL COMMITTEES:

Hackensack University Medical Center, Hackensack, NJ

2006. Institutional Review Board

2001 – Vice Chair

2001-2008 Institutional Animal Care Use Committee

2000 – Chair

2000- Pharmacy and Therapeutics Committee

2000- Biomedical Ethics Committee

2001- Infection Control Committee

2003- Surgical Infection Prevention (SIP) Co-Chair

2004- Surgical Care Improvement Project (SCIP) Chair

2009-2012 Data Safety Monitoring Board (Chair)

Conflict of Interest in Research (Chair)

University Hospital, Newark, New Jersey

2014- Bioethics Committee

2015 - Chair

SERVICE TO THE COMMUNITY:

None

SPONSORSHIP (Primary Mentorship) OF CANDIDATES FOR POSTGRADUATE DEGREE:

None

SPONSORSHIP (Primary Mentorship) OF POSTDOCTORAL FELLOWS:

None

TEACHING RESPONSIBILITIES:

A. Lectures or Course Directorships

Medical School Courses

2018 – R-NJMS/SGS MSBS 5015Q:

The Host Response to Injury

Lecture - Humanism and ethics in treating the severely ill

2016 – Patient-Centered Medicine

1st-Year Medical Students, small group faculty

12 weeks x 2.5 hrs

2015 – R-NJMS/GSBS GSND 5325

Introduction to Biomedical Ethics 2 Credit course

Course developer 2015

Course Director, fall semester, 2015-2017

Spring semester 2018

2015 – Advanced Communication Skills

2nd-Year Medical Student, small group faculty

6 weeks x 2.5 hrs

2014 – Ethics, Humanism and Professionalism

1st-Year Medical Student, small group faculty

8. weeks x 2.5 hrs

2013 – Surgical Clerkship Didactic Session,

“Organ Transplantation”, 1 hr, Q8weeks

2010 – Surgical Clerkship Director for St. George’s University students at Hackensack University Medical Center

1983-Instructor in surgical techniques course for first year Harvard Medical School Students, Beth Israel Hospital.

1983-Surgical Preceptor-Introduction to Clinical Medicine. Supervise second year students learning history and physical examination.

8 hours.

1984-Instructor, Surgical Core Clerkship

Precept third year clerks

20 hours per week; 12 weeks per year

Conduct seminar on transplantation for all core clerks

2 hours per seminar monthly

1986 - New Pathway Surgical Clerkship Committee

Redesigned surgical clerkship

Graduate Medical Courses/Seminars/Invited Teaching Presentations

2013- 2017 Surgical Residency Program Director, Rutgers-New Jersey Medical School

2012 – Site Program Director, Surgical Residency, NJMS/UMDNJ at HUMC

1. Director, transplant nephrology section, Nephrology fellowship program, New Jersey Medical School, UMDNJ

1988-1996- EMT Provider Course

Southwest Suburban EMS

Refresher courses

Continuing Medical Education Courses

1985- Instructor, Advanced Trauma Life Support

Re-certified 8/2/93

1-3 courses annually for providers and instructors

1996- Vascular Access: Issues & Innovations, Mystic, CT

Lectures on dialysis access, surgical issues

2016- Harvard Macy Institute – Program for Educators in the Health Sciences

Small Group Facilitator for: Microteaching

Journal Club

Project Group

Curriculum Development

Advisory and Supervisory Responsibilities in Clinical or Laboratory Setting

1983- Surgical Coordinator, Beth Israel Hospital

Administrator of didactic and clinical teaching of surgical house staff

1984- Attending on transplant service 12 months per year

Supervision of residents on transplant team, teaching of transplant fellows (2 per year)

2002- Supervisor, Nephrology Fellows (one at all times), New Jersey Medical School Nephrology Fellowship at HUMC

B. Research Training (other than Primary Mentorship)

None

CLINICAL RESPONSIBILITIES:

1996. Director, Pancreas Transplant Program, Beth Israel Hospital

1988-1999 Trauma Attending, reappointed 1993, Beth Israel Hospital

1996. Chief, Division of Transplantation, Beth Israel Hospital

1996-1999 Chief, Pancreas Transplantation, Division of Transplantation,

Beth Israel Deaconess Medical Center

1999-2012 Chief, Section of Organ Transplantation, Hackensack University Medical Center

2011-2012 Vice-Chair, Department of Surgery, Hackensack University Medical Center

2013- 2016 Chief, Division of General Surgery, R-NJMS, UH

GRANT SUPPORT:

A. Principal Investigator

1988-1993 NIH First Award R29AI25126-05

A study of specific cross-reactive alloimmunity following viral infections in mice.

Principal Investigator

1999. NIH, NIAID

Cooperative Clinical Trials in Adult Transplantation

Clinical trials of intervention in chronic allograft rejection

Site Principal Investigator

1988-1999 American Surgical Association Foundation Fellowship

$50,000/yr. x 2 yrs.

T Cell Control of Intra-abdominal Abscesses

T Cell regulation of Bacteroides fragilis abscesses in mice

Principal Investigator

9/95-8/97 Juvenile Diabetes Foundation

Islet Immunomodulation for Transplantation without Recipient

Immunosuppression

$50,000/yr. x 2 yrs.

Principal Investigator

1995-1998 Roche, Inc.

Phase III Clinical Trials of Humanized Anti-Tac in First Cadaver Renal Transplantation

Site Principal Investigator

1995-1999 Celltech, Ltd.

$130,000/yr direct

A study of anew, humanized monoclonal anti-class II antibody in renal transplants in macaques.

Principal Investigator

2003- Roche, Inc.

Phase IV Study of Dose vs. Concentration-controlled Cellcept dosing in solid organ transplantation

Site principal investigator

2006- Roche, Inc.

Valganciclovir Randomized Study in High Risk Kidney Allografts

Site principal investigator

2006 Roche, Inc.

Randomized Multicenter Trial of Oseltamivir in Immunocompromised Patients

Site Principal Investigator

2007 Bristol Myers Squibb

Belatacept Conversion Trial in Renal Transplantation

Site Principal Investigator

2010 The Molly and Lindsey Diabetes Research Foundation

HUMC-DRI Islet Cell Research Project

Principal Investigator

B. Co-Investigator

1991-1995 Boehringer, Ingleheim

BIRRI Renal Transplantation Trial

Phase III study of anti-ICAM in renal transplantation

Site Co-Investigator

1996-1999 Wyeth-Ayerst

Phase III Trails of Sirolimus (Rapamycin) in Human Renal Transplantation

Site Co-Investigator

C. Pending

None

PUBLICATIONS:

A. Refereed Original Article in Journal

1. Miller, R.E., Skukas, J., Violante, M.R. and Shapiro, M.E. “The Effect of Barium on Blood in the Gastrointestinal Tract.” Radiology, 1975; 117:527.

2. Fisher, H.W., Barbaric, Z., Violante, M.R., Stein, G., and Shapiro, M.E. “Iothalamate Ethyl Ester as Hepatolienographic Agent”. Invest. Radio. 1977; 12:96.

3. Violante, M.R., Shapiro, M.E., and Fisher, H.W. “Protein Binding to Iothalamate Ethyl Ester”. Invest. Radiol. 1979; 14:177.

4. Shapiro, M.E., Rodvein, R., Bauer, K.A., and Salzman E.W. “Acute Aortic Thrombosis in Antithrombin III Deficiency”. J. Amer. Med. Assoc. 1981; 245:1759.

5. Shapiro, M.E., Burakoff, S., Benacerraf, B., and Finberg, R.W. “IR Gene Control of the Cytotoxic T Lymphocyte Response to Sendai Virus: H-2k Mice are Low responders to Sendai”. J. Immunol. 1981; 127:2571.

6. Shapiro, M.E., Onderdonk A.B. Kasper, D.L. and Finberg, R.W. “Cellular Immunity to Bacteroids fragilis Capsular Polysaccharide”. J. Exp. Med. 1982; 155:1188.

7. Finbeg, R.W., Ertl, H.C.J., and Shapiro, M.E. “Virus-Specific Cytolytic Cells: Their in vivo function” Surv. Immunol. Res. 1982; 1:248.

8. Shapiro, M.E., Onderdonk, A.B., Kasper, D.L., and Finberg, R.W. “Immune T Cells Prevent Bacteroides fragilis Absceses”. Current Surgery. 1983; 40:123.

9. Hauser, S.L., Weiner, H.L., Che, M., Shapiro, M.E., Gilles, F., Letvin, N.L. “Prevention of experimental allergic encephalomyelitis (EAE) in the SJL/J mouse by whole body ultraviolet irradiation”. J. Immunol. 1984; 132:1276-81.

10. Hauser, S.L., Weiner, H.L., Bhan, A.K., Shapiro, M.E., Che, M., Aldrich, W.R. and Letvin, N.L. “Lyt-q cells mediate acute murine experimental allergic encephalomyelitis”. J. Immunol. 1984; 135.

11. Zaleznik, D.F., Finberg, R.W., Shapiro, M.E., Onderdonk, A.B., and Kasper, D.L. “A soluble suppressor T Cell factor protects against experimental intra-abdominal abscesses”. J. Clin. Invest. 1985; 75:1023.

12. Critchlow, J.F., Shapiro, M.E. Silen. W. “Duodenojejunostomy for the Pancreaticobiliary complications of Duodenal Diverticulum: Ann. Surg. 1985; 202:56.

13. Shapiro, M.E., Kasper, D.L., Zaleznik, D.F., Spriggs, S., Onderdonk, A.B., and Finberg, R.W. “Cellular control of abscess formation: Role of T cells in the regulation of abscesses formed in response to Bacteroides fragilis:. J. Immunol. 1986; 137:341.

14. Shapiro, M.E., Kirkman, R.L., Reed. M.G., Puskas, J.D., Mazoujian, G., Letvin, N.L., Carpenter, C.B., Milford, E.L., Waldmann, T.A., Strom, T.B., Schlossman, S.F. “Monoclonal Anti-IL-2 Receptor antibody in Primate Renal Transplantation”. Transplantation Proceedings. 1986; 19:594.

15. Reed, M.N., Shapiro, M.E., Strom, T.B., Milford, E.L., Carpentr, C.B., Letvin, N.L., Waldmann, T.A., Kirkman, R.L. “Prolongation of Primate Renal Allografts with Anti-TAC monoclonal antibody.” Curr. Surg. 1986; 45:28.

16. Carr, K., Dix,G., Fulmer,T., Kavesh,L., Kravitz,L., Matlaw, J., Mayer, J., Minaker, K., Shapiro, M., “An elder abuse assessment team in an acute hospital setting.” Gerontologist 1986 26:115-118.

17. Syndman, D.R., Werner, B.G., Heinz-Lacey, B., … Shapiro, M.E. … et. al. “Use of Cytomegalovirus Immune Globulin to Prevent Cytomegalovirus Disease in Renal Transplant Recipients”. N. Eng. J. Med. 1987; 317:1049.

18. Reed, M.H., Shapiro, M.E., Strom, T.B., Milford, E.L, Carpenter, C.B., Weinberg, D.S., Reimann, K.A., Letvin, N.L., Waldmann, T.A., and Kirkman, R.L. “Prolongation of Primate Renal Allograft survival by Anti-Tac, and Anti-Human IL-2 Receptor Monolclonal Antibody”. Transplantation. 1988; 47:55.

19. Syndman, D.R., Werner, B.G., Tilney, N.L. … Shapiro, M.E. … et. al. A further analysis of Primary Cytomegalovirus Disease Prevention in Renal Transplant Recipients with a Cytomegalovirus Immune Globulin: Interim Comparison of a Randomized and an Open Label Trial. Transplant Proc. 1988; 20, Supp. 18, 24.

20. Reed, M.H., Shapiro, M.E., Milford, E.L., Carpenter, C.B., and Kirkman, R.L., IL-2 receptor expression on peripheral blood lymphocytes in association with renal allograft rejection. Transplantation. 1989; 48:361.

21. Cahalane, M.J. Shapiro, M.E., Silen, W. “Abdominal incision: Decision or Indecision. Lancet. 1989; I, 146.

22. Kirkman, R.L., Shapiro, M.E., Carpenter, C.B., Milford, E.L., Ramos, E.L., Tilney, N.L., Waldmann, T.A., Zimmerman, C.E., and Strom, T.B. “Early Experience with Anti-TAC in Clinical Renal Transplantation”. Transplant Proc. 1989; 21:1766.

23. Ramos, E.L., Milford, E.L., Kirkman, R.L., Tilney, N.L., Strom, T.B., Shapiro, M.E., Waldmann, T.A., Wood, I.G., Rollins, M.R., Carpenter, C.B. “Differential IL-2 Receptor Expression in Renal Allograft Recipients Treated with an Anti-IL-2 Receptor Antibody”. Transplantation. 1989; 48:415.

24. Reed, M.H., Shapiro, M.E., Strom, T.B., Carpenter, C.R., Letvin, N.L., Reimann, K., Weinberg, D.S., Waldmann, T.A., Kirkman, R.L. “Anti-TACMOAB prolongs renal allografts in cynomolgus monkeys”. Transplant. Proc. 1989; 21:1028

25. Ramos, E.L., Leggat, J.E., Milford, E.L., Kirkman, R.L., Tilney, N.L., Strom, T.B., Shapiro, M.E., Waldmann, T.A., Carpenter, C.B. “In vivo anti-Interleukin-2 receptor (anti-TACO therapy is immunosupressive, but not tolerogenic. Trans. Assoc. Am. Physicians. 1989; 102:231-9.

26. Shapiro, M.E. “Use of Anti-IL-2 Receptor Monoclonal Antibodies for Immunosuppression. Transplant Management, 1990; 2:1.

27. Kirkman, R.L., Barret, L.V., Carter, P., Reed, M.H., Shapiro, M.E., RO-23-6457 Prolongs Survival of Vascularized Allografts in Rodents & Primates. J. Surg. Res. M 1990; 48, 304-307.

28. Kirkman, R.L., Shapiro, M.E., Carpenter, C.B., McKay, D.B., Milford, E.L., Ramos, E.L., Tilney, N.L., Waldmann, T.A., Zimmerman, C.B., Strom, T.B. A Randomized Prospective Trial of Anti-TAC Monoclonal Antibody in Human Renal Transplantation. Transplantation, 1991; 51:107.

29. Kirkman, R.L., Shapiro, M.E., Carpenter, C.B., McKay, D.B., Milford, E.L., Ramos, E.L., Tilney, N.L., Waldmann, T.A., Zimmerman, C.E., Strom, T.B., A randomized prospective trial of anti-TAC monoclonal antibody in human renal transplantation. Transplant Proc. 1991 Feb.; 23 (1 pt. 2) :1066-7.

30. Syndman, D.R., Werner, B.G., Tilney, N.L. … Shapiro, M.E. … and Grady, G.F. (24 authors). Final analysis of primary cytomegalovirus disease prevention in renal transplant recipients with a cytomegalovirus-immune globulin: Comparison of the random and open label trials. Transplant Proc. 1991; 23: 1357-1360.

31. Kim, D., Porter, D.H., Siegel, J.B., Shapiro, M.E., Strom, T.B. and Glotzer, D.J. Use of a reperfusion catheter after angioplasty dissection for salvage of ischemic renal allograft: case report. Cardiovasc. Intervent. Radiol. 1991; 14: 179-182.

32. Elahi, D., Clark, B.A., McAloon-Dyke, M., Wong, G., Brown, R., Shapiro, M.E., Minaker, K., Flanagan, K., Pruett, T., Gingerich, R., Hanks, J., and Anderson, D.K. Islet cell responses to glucose in human transplanted pancreas. Am J. Physiol., 1991; 261: E800-E808.

33. Lipman, M.L., Stevens, C., Bleackley, R.C., helderman, J.H., McCune, T.R., Harmon, W.E., Shapiro, M.E., Rosen, S., and Strom, T.B. The Strong Correlation Cytotoxic T Lymphocyte specific serine protease gene transcripts with renal allograft rejection. Transplantation 1992; 53:73-79.

34. Elahi, D., McAloon-Dyke, M., Clark, B.A., Kahn, B.B., Weinreb, J.E., Minaker, E.L., Wong, G.A., Morse, L.A., Brown, R.S., Shapiro, M.E., et. Al. Sequential evaluation of islet cell responses to glucose in the transplanted pancreas in humans. Am. J. Surg. 1993; 165:15.

35. Bennett, W.M., Carpenter, C.B., Shapiro, M.E., Strom, T.B., Hefty, D., Tillman, M., Abrams, J., Ryan, D., and Kelley, V.R. Delayed omega-3 fatty acid supplements in renal transplantation: a double blind, placebo-controlled study. Transplantation, 1995; 59: 352-356.

36. Shapiro, M.E., and Liu, M. Prolongation of Islet Allograft survival by Anti-CD45 Antibody Pretreatment. Transplant Proc., 1995; 27:613-14.

37. Meisels, I.S., Strom, T.B., Roy-Chaudhury, P., Abrams, J., and Shapiro, M.E. Renal Allograft Rejection in a Patient with the Wiskott-Aldrich Syndrome. Transplantation; 1995; 59:1214-15.

38. Liu, M., Shapiro, M.E. A new method for isolation of murine islet with markedly improved yields. Transplant Proc., 1995; 27:3208-10.

39. Liu, M., Shapiro, M.E. Causes of Islet Allograft Primary Non-Function. Transplant Proc., 1995; 27:3205-07.

40. Shapiro, M.E., Abrams, J.M., Brown, R.S., Steinman, T.I., Strom, T.B. Successful Pancreas-Renal Transplantation Without Anti-T Cell Antibody Induction. Transplant Proc., 1995; 27:3007-08.

41. Pavlakis, M., Strehlau, J., Lipman, M., Shapiro, M., Maslinski, W., and Strom, T.B. Intragraft IL-15 Transcripts are Increased in Human Renal Allograft Rejection. Transplantation, 1996; 62:543-545.

42. Strehlau, J., Pavlakis, M., Lipman, M., Maslinski W., Shapiro, M., Strom, T.B. The Intragraft Gene Activation of Markers Reflecting T-Cell Activation and Cytotoxicity Analyzed b Quantitative RT-PCR in Renal Transplantation. Clin. Nephrol., 1996; 46:30.

43. Strehlau, J., Pavlakis, M., Lipman, M., Shapiro, M., Vasconcellos, L., Harmon, W., Strom, T.B. Quantitative detection of immune activation transcripts as a diagnostic tool in kidney transplantation. Proc. Natl. Acad. Sci. USA, 1997; 94:695-700.

44. Avigan, D., Richardson, P., Elias, A., Demetri, G., Shapiro, M., Schnipper, L., Wheeler, C. Neutropenic enterocolitis as a complication of high dose chemotherapy with stem cell rescue in patients with solid tumors: A case series with a review of the literature. Cancer, 1998; 165; 15-22.

45. Zheng, X.X., Schacter, A.D., Vasconcellos, L., Strehlau, J., Tian, Y, Shapiro, M., Harmon, W., Strom, T.B. Increased CD40 ligand gene expression during human renal and murine islet allograft rejection. Transplantation, 1998, 65:1512-5.

46. Vasconcellos, L.M., Asher, F., Schacter, A.D., Zheng, X.X., Vasconcellos, L.H., Shapiro, M., Harmon, W.R., Strom, T.B. Cytotoxic lymphocyte gene expression in peripheral blood leukocytes correlates with rejecting renal allografts. Transplantation, 1998, 66:562-6.

47. Shapiro, M.E., “The development of new allocation policy for deceased donor kidneys.” Curr Opin Nephrol, Hypertens., 2007, 16: 512-515.

48. Disick, G.I.S., Shapiro, M.E., Miles, R.A., Munver, R. Critical analysis of laparoscopic donor nephrectomy in the setting of complex renal vasculature: initial experience and intermediate outcomes. J. Endourology, 2009, 23:451-5. PMID 19245297

49. Danovitch, G.M., Shapiro, M.E., Lavee, J. The use of executed prisoners as a source of organ transplants in China must stop. AJT, 2011, 11:426-428. PMID 21342444

50. Shapiro, M.E., Age should be considered in the allocation of deceased donor kidneys. Seminars in Dialysis, 2012, 25:682-685. PMID 23173894

51. Huige, L., Shapiro, M.E., Els, C., Allison, K.C. Organ transplantation in China: concerns remain. The Lancet, 385, 855-856, 2015. PMID 25773091

52. Shapiro, M.E. and Ward, F.R., The Problem with DCDD is the Dead Donor Rule, American Journal of Bioethics, 2015,15: 15-16. PMID 26225506

53. Oliver, J.B., Beidas, A.K., Bongu, A., Shapiro, M.E., A comparison of long-term outcomes of portal versus systemic venous drainage in pancreatic transplantation: a systematic review and meta-analysis, Clinical Transplantation, 2015, PMID 26172035.

54. Allison, K.C., Caplan, A., Shapiro, M.E., Els. C., Paul, N.W. Li, H., Historical development and current status of organ procurement from death-row prisoners in China, BMC Medical Ethics, 2015, 16:85-91. PMID 26630929.

55. Le, V., Kurnutala, L., SchianodiCola, J., Ahmed, K., Yarmush, J., Eloy, J., Shapiro, M., Haile, M., Bekker, A., Premedication with intravenous ibuprofen improves recovery characteristics and stress response in adults undergoing laparoscopic cholecystectomy: a randomized controlled trial, Pain Medicine, 2016, PMID 26893119.

56. Shapiro, M.E. and Ward, F.R., Autonomy Means Having to Make a Choice, American Journal of Bioethics, 2016, 16: 19-20. PMID 27749171.

57. Paul, N.W., Caplan, A., Shapiro, M.E., Els, C., Allison, K.C., Li, H., Human rights violations in organ procurement practice in China, BMC Medical Ethics, 2017; 18:11 PMID 28178953.

58. O’Neill, R., Shapiro, M., Merchant, A., The Role of the Operating Room in Medical Student Education: Differing perspectives of learners and educators, J Surg Ed, 2018; 75: 14-28. PMID 28712688.

59. Paul, N.W., Caplan, A., Shapiro, M.E., Els, C., Allison, K.C., Li, H., Determination of Death in Execution by Lethal Injection in China, Cambridge Quarterly of Healthcare Ethics, 2018; 27:459-466. PMID 29845916.

60. Shapiro, M.E. and Ward, F.R., Uterus Transplantation: A step too far, American Journal of Bioethics, 2018, 18 (7): 36-37. PMID 30040573.

61. Shapiro, M.E.,

B. Books, Monographs and Chapters

1) Diamanstein, T., Osawa, H., Kirkman, R.l., Shapiro, M.E., Strom, T.B., Tilney, N.L., and Kupiec-Weglinski, J.W. “Interleukin 2 Receptor – A Target for Immunosuppressive Therapy.” Transplantation Reviews P.J. Morris and N.L. Tilney (eds), Grune and Stratton, 1987; Vol. 1.

2) Strom, T.B., Kelley, V.E., Murphy, J.R., Osawa, H., Tileny, N.L., Shapiro, M.E., Kupiec-Weglinski, Diamanstein, T., Gaulton, G.N., and Kirkman, R.L. “Interleukin – 2 Receptor Directed Immunosuppressive Therapy.” In Molecular Basis of Lymphokine Action, 1987. D.R. Webb, C.W., Pierce, S.

3) Shapiro, M.E., Intra peritoneal Abscess. In: Taylor, M.B., Gollan, J.L., Peppercorn, M.D., Steer, M.L., Wolfe, M.M., eds. Gastrointestinal Emergencies. Baltimore: Williams and Wilkins, 1991; 491-496.

4) Shapiro, M.E., Bacteroides, Infection and Immunity. In: Roitt, I.M., Delves, P.J., eds. Encyclopedia of Immunology. Orlando: W.B. Saunders, 1991; 218-219.

5) Shapiro, M.E., Kirkman, R.L., Rubin-Kelley, V.E., Bacha, P., Nichols, J. and Strom, T.B. In Vivo Studies with Chimeric Toxins. Interleukin-2 Fusion Toxins as Immunosuppression Agents. Targeted Diagnosis and Therap, 1992; 7:383.

6) Shapiro, M.E., Pancreas Transplantation in: Austen, K.F., Burakoff, S.J., Rosen, F., and Strom, T.B., ed.,: “Therapeutic Immunology” Blackwell Science, 1996; 465-8.

7) Shapiro, M.E., Pancreas Transplantation, in: Austen, K.F., Burakoff, S.J., Rosen, F., and Strom, T.B., eds., “Therapeutic Immunology” 2nd Ed., Blackwell Science, 2001, 469-473.

C. Patents Held

None

D. Other Articles (Reviews, Editorials, etc.) In Journals; Chapters; Books; other Professional Communications

1) Shapiro, M.E., Salzman, E.W., Aortic Thrombosis in Antithrombin III deficiency – Reply, JAMA 247:1127-8.

2) Onderdonk, A.B., Shapiro, M.E., Finberg, D.F., Zaleznik and Kasper, D.L. “Use of a model of intra-abdominal sepsis for studies of the pathogenesis of Bacteroides fragilis. Rev. Infect. Dis., 1984; 6: S91

3) Williams, J.M., Kelley, V.E., Kirkman, R.L., Tilney, N.L., Shapiro, M.E., Murphy, J.R., and Strom, T.B. “T Cell Activation Antigens: Therapeutic Implications” Immunological Investigations, 1987-1988; 16 (8).

4) Carpenter, C.B., Kirkman, R.L., Shapiro, M.E., Milford, E.L., Tilney, N.L., Waldmann, T.A., Zimmerman, C.E., Ramos, E.L., Strom, T.B., Prophylactic Use of Monoclonal Anti-IL-2 Receptor Antibody in Cadaveric Renal Transplantation. Am. J. Kidney Dis. 14, Suppl., 2; 1989; 54-57.

5) Shapiro, M.E., Reed, M.H., Strom, T.B., Carpenter, C.B., Milford, E.L., Kirkman, R.L. The Role of primate Model of Renal Transplantation in the Development of new Monoclonal Antibodies. Am. J. Kidney Dis. 14 Suppl. 2; 1989, 58-60

6) Critchlow, J.T., Shapiro, M.E., Silen, W. Symptomatic duodenal diverticulum, World J. Surg., 20:118, 1996.

7) Shapiro, M.E., Abrams, J.M., Valacyclovir to Prevent Cytomegalovirus Disease after Renal Transplantation (letter). N. Eng. J. Med., 341: 921, 1999.

8) Shapiro, M.E. and Abrams, J.M., Is Kidney Transplantation Lifesaving? (letter). Am. J. Kidney Dis., 38:221-2, 2001.

9) Shapiro, M.E., When Hospitals Shop Abroad (letter). The New York Times, July 29, 2001.

10) Shapiro, M.E., Cadaveric or Living Donors? (letter). Contemporary Surgery, 58:135, 2002.

11) Shapiro, M.E. Book Review, Transplantation of the Pancreas, Gruessner, R. W. G and Sutherland, D. E. R., eds, N Eng J Med, 2006, 353:1534-5.

12) Lovallo, G.G., Volfson, I.A., Shapiro, M.E., Munver, R., Laparoscopic Live Donor Nephrectomy in the Presence of a Circumaortic Renal Vein: The Video. J Endourology 2006 20:A301.

13) Shapiro, M.E., The Politics of Doctors (letter). The New York Times, June 3, 2011.

14) Danovitch, G.M.., Shapiro, M.E., Lavee, J. The Use of Executed Prisoners as a Source of Organ Transplants in China Must Stop. AJT, 11:1342, 2011.

15) Caplan, A.L., Danovitch, G., Shapiro, M., Lavee, J., Epstein, M. Time for a boycott of Chinese science and medicine pertaining to organ transplantation. The Lancet, 378:1218, 2011.

16) Shapiro, M.E. and Strong, C.W. Heroes Act Podcast 1 – Legal and Ethical Standards: Meeting the Standards for Organ Donation – Why Should Physicians and Nurses Act? UMDNJ, Oct 17, 2011.

17) Shapiro, M.E., Heroes Act Podcast 2 – Clinical Practice Guidelines: Determining the Eligibility and Medical Suitability of Organ Donors. UMDNJ, Oct 17, 2011.

18) Allison, K.C., Paul, N.W., Shapiro, M.E., Els, C., Li, H. China’s semantic trick with prisoner organs. BMJ (online) 10/2015.

19) Caplan, A., Trey, T., Shapiro, M., Fiatarone Singh, M., Engagement or Isolation? Organ Trafficking Persists in China. Georgetown Journal of International Affairs (online). 6/13/2017.

20) Shapiro, M.E., A Plan to Decrease Fertility (letter). The New York Times, October 27, 2017

E. Abstracts

1. May, R., Yamato, S., Greenberg, H., Shapiro, M.E., 1990. Outcome of Subtotal Colectomy in Severe Idiopathic Constipation: Importance of Radio-opaque Marker Studies. Gastroenterology 98: 1990; 1374

2. Vasconcellos L., Pavlakis, M., Strehlau, J., Shapiro, M., Harmon, W., Strom, T.B., RANTES and IL-* : Intragraft chemokine transcript expression in human renal allografts. JASN 1996 7:A3257.

3. Shapiro, M.E., Liu, M., Smith, R., Saxton N., Nesbitt, A., Foulkes, R. Anti-MHC Class II Mabs suppress allogeneic responses in solid organ transplantation in mice and primates. Transplantation, 1998, 65:S9

4. Hanks, J., McAloon-Dyke, M., Clark, B., Kahn, B., Weinreb, J., Minaker, K.L., Wong, G., Morse, L., Brown, R., Shapiro, M., Gingerich, L., Rosenlof, L., Pruitt, T., Anderson, D.K., Elahi, D. Insulin Response, glucose homeostasis, and glut4 levels in muscle after pancreas transplant. Comparison of initial study with one year follow-up. Regulatory Peptides, 1992 40:166.

5. McAloon-Dyke, M., Earnhardt, R., Hanks, J.B., Pruitt, T., Minaker, K.L., Shapiro, M., Brown, R., Habener, J.F., Andersen, D.K., Gingerich, R.L., Elahi, D. Insulinotropic effect of GLP-1 in portally or systemically drained pancreas transplant patients. Clinical Research 1993 41:A157.

6. Pavlakis, M., Strehlau, J., Vasconcellos, L., Shapiro, M., Harmon, W., Strom, T.B., Post-transplant recurrent focal segmental glomerulosclerosis (rFS) : Intragraft gene expression JASN 1996 7:A3453.

7. Shapiro, M.E., Ford, P., Abrams, J.M., Successful renal transplantation in the elderly; an excellent option for renal replacement therapy. 7th International Conference on Geriatric Nephrology and Urology, Int. Urol. And Nephrol., 34:585, 2002.

8. Shapiro, M.E., DeGroote, R., Bogomol, A., Lieberman, K., Use of the Superior Mesenteric Vein for Renal Transplantation in Vena Cava Occlusion. 4th Annual ASTS Winter Symposium, Scottsdale, AZ, 1/24/04.

9. Woodle, E.S., Mulgaonkar, S., Rees, M., Palekar, S., Goldfarb, D., Swannick, K, Aeder, M., Shapiro, M., Lal, T., Radomski, J. Transplantation 2006 82:632-633.

10. Shapiro, M.E., There is No Right to a Transplant, XXII International Congress of the Transplantation Society, Sydney, Australia, 8/12/08.

11. Shapiro, M.E., Abrams, J.M., Steroid-Free Immunosuppression for Kidney Transplantation in Bipolar Disorder Lithium Toxicity, XXII International Congress of the Transplantation Society, Sydney, Australia, 8/14/08.

12. Desai, K.K., Shareef, A., Raza, A., Mulgaonkar, S., Laskow, D., Osband, A., Shapiro, M., Radomski, J., Guy, S., Goldblatt, M., Dikdan, G., Koneru, B., Ischemic preconditioning of the liver in deceased donors - suggestive evidence of remote preconditioning in kidney allografts. Liver Transplantation 2009 15:S101.

13. Wu, G.C., Lieberman, K.V., Ettinger, L.M., Abrams, J.M., and Shapiro, M.E., Alemtuzumab induction may exacerbate antibody-mediated rejection in pediatric renal transplant recipients Am J Transplantation 2010 10:14.

14. Yates, J.K., Shapiro, M., Wu, G., Ackerman, A., Munver, R., Retrograde endoscopic access for the management of ureteral complications after renal transplantation: success rate increases with experience. J. Endourology 2011 25:A132-133.

15. Luker, J., Goerlitz, F., Sosnicki, R., Reitsma, W., Ali, N., Shapiro, M., Bacterial Meningitis Does Not Preclude Deceased Organ Donation, 7th National Learning Congress, Donation and Transplantation Community of Practice, Grapevine, TX, 10/4/12.

F. Reports

PRESENTATIONS:

A. Scientific:

None

B. Professional: (abridged)

Invited Speaking Presentations

Grand Rounds, “Surgical Care Improvement Project,” East Orange Hospital, East Orange New Jersey, 9/19/06.

Pediatric Grand Rounds, Morristown Memorial Hospital, “Organ Donation, Brain Death and DCD”, Morristown, NJ, 9/21/06

Combined Surgical/Anesthesia Grand Rounds, Hackensack University Medical Center, “Surgical Care Improvement Project,” 10/3/06

Surgical Grand Rounds, Hackensack University Medical Center, “Current Challenges in Organ Donation,” 12/12/06

Pediatric Grand Rounds, “Pediatric Organ Donation and Transplantation,” Jersey City Medical Center, 3/1/07.

Organ Donation after Cardiac Death

St Clare Hospital, Denville, NJ, 6/6/06

Chilton Memorial Hospital, Pompton Plains, NJ, 6/14/06

Community Medical Center, Toms River, NJ, 7/27/06

Clara Maas Medical Center, Belleville, NJ, 9/20/06

Barnert Memorial Hospital, Paterson, NJ, 3/9/07

Palisades Medical Center, North Bergen, NJ, 4/11/07

Bayonne Medical Center, Bayonne, NJ, 4/20/07

Ocean Medical Center, Brick, NJ, 5/17/07

OPTN/UNOS Public Forum, Kidney Allocation Policy Development, “Ethical Issues in Organ Allocation”, Dallas, TX, 2/8/07

OPTN/UNOS 15th Management Forum, “Toward a New Organ Allocation System,” Washington, DC, 4/24/07

The vital role of the intensivist in maximizing Organs for Transplantation, “When Good Organs Go Bad,”, Baltimore, MD, 9/18/07

2007 International Society for Organ Donation and Procurement Congress, “Kidney Allocation in the U.S.,” Philadelphia, PA, 11/14/07

“Surgical Care Improvement Project”, Richmond, VA, 12/3/07.

Visiting Professor, Urology, Hackensack University Medical Center, “Renal Transplant 2010”, 1/15/10

Medical Grand Rounds, Hackensack University Medical Center,

“Ethical Issues in Organ Transplantation,” 2/2/10

GI Symposium, Rutgers – New Jersey Medical School, “Minimally Invasive Surgery: Are We There Yet?”, 6/7/2014

Surgery Grand Rounds, Rutgers – New Jersey Medical School, “Surgical learning-It is Not Just Powerpoint Anymore,” 9/11/2015

Radiology Grand Rounds, Rutgers – New Jersey Medical School, “Graduate Medical Learning - It is Not Just Powerpoint Anymore,” 10/1/2015

Medical Grand Rounds, Rutgers – New Jersey Medical School, “Graduate Medical Learning - It is Not Just Powerpoint Anymore,” 2/9/2016

Anesthesia Grand Rounds, Rutgers – New Jersey Medical School, “Ethics in the Operating Room,” 2/10/2016.

Surgery Grand Rounds, Rutgers-New Jersey Medical School, “Ethics in the Operating Room,” 4/29/2016

Surgery Grand Rounds, Rutgers – New Jersey Medical School, “Surgical Site Infections: Theory, Prevention, Treatment,” 9/16/16

Graduate Medical Education Faculty Development Rounds , “Graduate Medical Learning - It is Not Just Powerpoint Anymore,” 9/16/16

Surgery Grand Rounds, Hackensack University Medical Center, “Graduate Medical Learning - It is Not Just Powerpoint Anymore,” 9/20/16

Grand Rounds, St. Mary’s Hospital, Passaic, “Update on Thyroid and Parathyroid Disease,” 9/28/16

Grand Rounds, Easton Hospital, Easton, PA, “Surgical Site Infections”, 3/24/17

National Kidney Foundation, Greater NY Annual Regional Symposium, New York, NY, “Organ Trafficking and Transplant Tourism”, 3/31/17

Grand Rounds, Woodhull Hospital, Brooklyn, NY, Ethical Issues in Kidney Transplantation, 1/26/18.

Grand Rounds, NYU, Division of Nephrology, Organ Trafficking and Transplant Tourism, 6/11/18.

................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download